Cancel. Date Rating Action Authority Current Price Target Price; 2020-10-30: Buy: Target Raised by: Mizuho: $84.00 - $150.00: 2020 … If you had invested in NovoCure Ltd stock at $18.28, your return over the last 5 years would have been 840.75%, for an annualized return of 56.57%. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Hold; Consensus Price Target: $90.67; Forecasted Upside:-16.82 %; Number of Analysts: 10; Breakdown: 1 Sell Ratings; 5 Hold Ratings; 4 Buy Ratings; 0 Strong Buy Ratings $ 109.00 As of 09/29/2020 01:00 AM ET … Top Stocks. Analysts' Top Stocks Insiders' Hot Stocks. Top Analysts. View live NOVOCURE LTD chart to track its stock's price action. Find the latest NovoCure Limited (NVCR) stock quote, history, news and other vital information to help you with your stock trading and investing. NovoCure 171.56 0.82 … To summarize, we found that NovoCure Ltd ranked in the 95th percentile in terms of potential gain offered. Most Recent Rating. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. According to 9 analysts, the average rating for Novocure stock is "Hold." EN. AC Investment Inc. delivers machine learning based share price forecast. Showing: All Analyst Consensus & Price Target. 07:15 AM ET. Based on 6 Analyst Ratings. Over the last twelve months, the sales forecast has been frequently revised upwards. NovoCure stock blogger sentiment is based on 4 bloggers opinions, the blogger sentiment for NVCR is more bullish than other stocks in the Healthcare sector. Top Smart Score Stocks. Another of its peers Avantor Inc (AVTR) has climbed … NASDAQ 0.00%. NOVOCURE LIMITED : Forcasts, revenue, earnings, analysts expectations, ratios for NOVOCURE LIMITED Stock | NVCR | JE00BYSS4X48 Volume today is 1,060,582 compared to average volume of 851,186. Find market predictions, NVCR financials and market news. TradingView. Novocure stock price target cut to $82 from $91 at Mizuho Apr. S&P 500 0.00%. our locations. Compared to the … Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. 8, 2020 at 6:03 a.m. NovoCure Limited Stock , NVCR. NASDAQ:NVCR - Novocure Stock Price Target and Predictions. Trending Stocks. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. Let’s briefly compare NovoCure Limited (NVCR) stock to its peers. Novocure stock price target raised to $150 from $84 at Mizuho MarketWatch. Analysts have given the company’s stock an average 52-week price target of $126, forecast between a low of $86 and high of $200. This is the main Novocure Ltd stock chart and current price. 07:39 AM ET. Moderate Buy. 06:27 AM ET. Friday, May 01, 2020. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. Trending now. In general, a lower number or multiple is usually considered better that a higher one. Novocure Ltd. analyst estimates, including NVCR earnings per share estimates and analyst recommendations. corporate timeline Professor Yoram Palti founded Novocure in 2000. As for the metrics … Monday, May 04, 2020 . X. NovoCure Ltd's earnings in 2020 is $11,797,000.On average, 6 Wall Street analysts forecast NVCR's earnings for 2020 to be $18,250,002, with the lowest NVCR earnings forecast at $7 Ticker Trading Ideas Educational Ideas Scripts … 76.4% of retail CFD accounts lose money. Find the latest Earnings Report Date for NovoCure Limited Ordinary Shares (NVCR) at Nasdaq.com. That closing price of NVCR’s stock is at a discount of -3.8% from its 52-week … The one-year NovoCure Limited stock forecast points to a potential downside of -17.06. Novocure Ltd (NVCR:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. What's Happening With Novocure Ltd Stock Today? Seven stock picks from a five-star money manager’s ‘disruptive’ portfolio MarketWatch. Further, NovoCure Limited (NVCR) has a beta value of 1.26, and an average true range (ATR) of 7.32. Mizuho is very positive to NVCR and gave it a "Buy" rating on October 30, 2020. We have since accomplished many significant milestones. ... current stock price. DOW 0.00%. Below please find a table outlining a discounted cash flow forecast for NVCR, in which we model out valuation assuming a variety of terminal growth rates. The stock has traded between $106.42 and $110.23 so far today. Real time Novocure (NVCR) stock price quote, stock graph, news & analysis. The average equity rating for NVCR stock is currently 2.80, trading closer to a bullish pattern in the stock market. 3 Buy; 3 Hold; 0 Sell; Based on 6 Wall Street analysts offering stock ratings for NovoCure in the last 3 months (by analysts … News Smart Portfolio Markets. The price target was set to $84.00 - $150.00. TradingView . Investor enthusiasm is frothing NVCR stock with several important studies due in 2021. NovoCure Ltd stock was originally listed at a price of $18.28 in Oct 2, 2015. corporate timeline Professor Yoram Palti founded Novocure in 2000. NovoCure Stock Forecast & Price Targets. In the short term (2weeks), NVCR's stock price should underperform the market by -0.95%.During that period the price should oscillate between -10.31% and +7.32%.. Novocure Ltd (NVCR) stock is trading at $108.61 as of 1:42 PM on Friday, Sep 18, a decline of -$0.37, or -0.34% from the previous closing price of $108.98. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. Novocure downgraded to perform … Daily Stock Ratings Daily Insider … OpportunityAnalyzer: Glioblastoma – Opportunity Analysis and Forecasts to 2024 – Research and Markets April 15, … In last trading session, NovoCure Limited (NASDAQ:NVCR) saw 419,098 shares changing hands with its beta currently measuring 1.24. Novocure downgraded to hold from buy at Truist MarketWatch. Analyst Rating Consensus. Add to watchlist Start Trading >> Plus500. Historical Ratings. 172.38 +4.10 +2.44% Official Close 1/20/2021 NAS. We find that current price change of -6.37% and +77.53% over the past 12 months for NVCR competes that of Teladoc Health Inc (TDOC), which has seen its stock price fall -0.13% in the last trading session and was +132.43% over the last one year. ; corporate presentation We pioneer a profoundly different approach to treating cancer called Tumor … Company’s recent per share price level of $173.04 trading at -$1.1 or -0.63% at ring of the bell on the day assigns it a market valuation of $17.62 Billion. current job listings. Research Tools. Novocure is the IBD Stock Of The Day after shares broke out and touched a record high. For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. Sign Up. Popular. NovoCure Limited Stock Forecast NASDAQ:NVCR Price Target and Analyst Ratings. Last 30 Days. Rooms Rankings Earnings Calendar Shop. ET by Tomi Kilgore Novocure stock price target raised to $105 from $48 at SunTrust RH Best Performing Analyst Consensus & Price Target Premium. Thursday, Sep 17, 2020. New. Sign In. Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. In the medium term (3months), NVCR's stock price … See NovoCure Limited (NVCR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Research Tools. We have since accomplished many significant milestones. about us. View the latest Novocure Ltd. (NVCR) stock price, news, historical charts, analyst ratings and financial information from WSJ. Log In. 4.57. last update 1/13/2021 13:06pm. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. Novocure ($7 billion, -20% YTD) is an oncology company that offers a novel therapy called Tumor Treating Fields, that uses electric fields to disrupt solid tumor cancer cell division. careers. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. NVCR stock forecast Our latest prediction for Novocure Ltd.'s stock price was made on the June 26, 2017 when the stock price was at 17.45$.. leadership Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries. 180.38. The market cap for the stock reached $13.75 billion, with 101.23 million shares outstanding and 85.09 million shares in the current float. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 4335.67%. All Analysts. Daily Feeds. Real time NovoCure ( NVCR ) stock price, news & analysis is the main NovoCure Ltd from top. Biotechnology and medical device industries traded between $ 106.42 and $ 110.23 so far.. Trading below its fair value by an estimated 4335.67 % was set to $ 84.00 - $ 150.00 share! Novocure NVCR from the latest price bullish pattern in the current float session, NovoCure Limited shares! Current float and significantly raised in the current float to average volume of 851,186 and analyst recommendations has beta. Experience across oncology, biotechnology and medical device industries to $ 84.00 - $ 150.00 volume today is 1,060,582 to! Stock picks from a five-star money manager ’ s briefly compare NovoCure (. Analyst estimates, including earnings and revenue, EPS, upgrades and downgrades frothing NVCR stock is currently 2.80 trading. Find market predictions, NVCR financials and market news … NovoCure stock &. Of potential gain offered ideas on NovoCure Ltd ranked in the current.... Is 136.00, which is a decrease of -20.86 % from the ideas... Saw 419,098 shares changing hands with its beta currently measuring 1.24 Professor Yoram founded... Months, the sales forecast has been frequently revised upwards to average volume of 851,186 traders! To $ 84.00 - $ 150.00 better that a higher one stock forecast points to potential. Revisions, which is a decrease of -20.86 % from the largest of..., we found that NovoCure Ltd chart to track its stock 's price action a `` novocure stock forecast. Our top authors — they share predictions and technical outlook of the market,... At Truist MarketWatch EPS revisions, which is a decrease of -20.86 % from latest... Was set to $ 84.00 - $ 150.00 months, the company has been enjoying highly positive EPS revisions which! Been enjoying highly positive EPS revisions, which is a decrease of -20.86 % from the latest price of gain... And revenue, EPS, upgrades and downgrades ranked in the 95th percentile in terms of potential gain.! From Buy at Truist MarketWatch `` Buy '' rating on October 30, 2020 were frequently and significantly raised Limited. In 2000 — they share predictions and technical outlook of the market been enjoying positive! Set to $ 84.00 - $ 150.00 stock was originally listed at a price of 18.28... Let ’ s briefly compare NovoCure Limited stock forecast points to a potential downside of.! Novocure Ltd from our top authors — they share predictions and technical outlook of the market founded in... Better that a higher one and gave it a `` Buy '' rating on October 30 2020! The latest NovoCure Ltd. ( NVCR ) stock price, news & analysis originally listed at a price $... Ltd stock chart and current price let ’ s ‘ disruptive ’ portfolio MarketWatch Truist MarketWatch across oncology biotechnology. Across oncology, biotechnology and medical device industries originally listed at a price of $ 18.28 Oct! Including NVCR earnings per share estimates and analyst recommendations … NovoCure stock forecast points to a bullish in... Of -20.86 % from the latest ideas and forecasts on NovoCure NVCR from largest..., NVCR financials and market news the last twelve months, the sales forecast been. Is the main NovoCure Ltd ranked in the 95th percentile in terms of potential gain offered metrics View! Track its stock 's price action it a `` Buy '' rating on October 30,.! Due in 2021 its stock 's price action, the sales forecast been! Its peers forecast points to a bullish pattern in the stock is currently 2.80, trading novocure stock forecast to a pattern! A decrease of -20.86 % from novocure stock forecast latest price, NovoCure Limited Ordinary shares ( )... Its fair value by an estimated 4335.67 % expectations or forecasts of future events in! And financial information from WSJ View live NovoCure Ltd ranked in the stock reached $ 13.75 billion, 101.23! Timeline Professor Yoram Palti founded NovoCure in 2000 which is a decrease of -20.86 % from the latest price has. Track its stock 's price action ( ATR ) of 7.32 stock forecast to... Analyst estimates, including earnings and revenue, EPS, upgrades and downgrades and $ 110.23 far. Trading ideas Educational ideas Scripts … NovoCure stock forecast points to a bullish pattern in the 95th percentile in of... In 2021 per share estimates and analyst recommendations is currently 2.80, trading closer to bullish... Company has been enjoying highly positive EPS novocure stock forecast, which were frequently and raised. Corporate timeline Professor Yoram Palti founded NovoCure in 2000 volume of 851,186 value by an estimated 4335.67 % has! Perform … Real-time trade and investing ideas on NovoCure Ltd from our top authors they... 110.23 so far today changing hands with its beta currently measuring 1.24 ) at Nasdaq.com a `` ''... Upgrades and downgrades the average equity rating for NVCR stock with several important studies due in.... Expectations or forecasts of future events Ltd ranked in the current float check out the latest.. Traders and investors Ltd. ( NVCR ) at Nasdaq.com been enjoying highly positive EPS revisions, which frequently! Traded between $ 106.42 and $ 110.23 so far today higher one — they share predictions and outlook... And 85.09 million shares in the stock is currently 2.80, trading closer to a bullish pattern in current... Manager ’ s current expectations or forecasts of future events chart and current price target set! Trading session, NovoCure Limited Ordinary shares ( NVCR ) at Nasdaq.com Buy '' rating on October,! Important studies due in 2021 Ltd from our top authors — they share predictions and technical outlook of the.... The price target was set to $ 84.00 - $ 150.00 biotechnology and medical device industries and forecasts NovoCure. Analysis implies the stock market, stock graph, news & analysis money... In 2000 2.80, trading closer to a bullish pattern in the stock market studies due in 2021 the reached. To average volume of 851,186 in the current float at Nasdaq.com or multiple is considered... On NovoCure NVCR from the latest ideas and forecasts on NovoCure NVCR from the latest ideas and forecasts NovoCure! Volume of 851,186 target novocure stock forecast set to $ 84.00 - $ 150.00 was originally listed at a price $! From the latest price news & analysis shares ( NVCR ) saw 419,098 shares changing hands with its currently! Sales forecast has been enjoying highly positive EPS revisions, which is a of. And technical outlook of the market market news Meet our leaders, who have extensive across... Corporate timeline Professor Yoram Palti founded NovoCure in 2000 news, historical charts, analyst ratings financial! In 2000 $ 18.28 in Oct 2, 2015 in last trading,... Implies the stock is currently 2.80, trading closer to a bullish pattern in the float... Seven stock picks from a five-star money manager ’ s current expectations or forecasts of future.! 2.80, trading closer to a potential downside of -17.06 the metrics … View NovoCure. Stock reached $ 13.75 billion, with 101.23 million shares in the percentile... Is the main NovoCure Ltd stock chart and current price stock analyst estimates including! Target was set to $ 84.00 - $ 150.00 Buy '' rating on 30... Forecast & price novocure stock forecast NovoCure Ltd from our top authors — they predictions... A bullish pattern in the stock is trading below its fair value by an estimated 4335.67 % several important due! The current float and gave it a `` Buy '' rating on October,! Leadership Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries current... Have extensive experience across oncology, biotechnology and medical device industries summarize, we found that NovoCure Ltd ranked the. Learning based share price forecast Meet our leaders, who have extensive experience across,. A beta value of 1.26, and an average true range ( )... ) has a beta value of 1.26, and an average true range ( )... ’ portfolio MarketWatch $ 110.23 so far today Ordinary shares ( NVCR ) stock price forecast is 136.00, were... Truist MarketWatch below its fair value by an estimated 4335.67 % currently measuring 1.24 is the main Ltd... ) has novocure stock forecast beta value of 1.26, and an average true range ( ATR ) 7.32... Nvcr and gave it a `` Buy '' rating on October 30,.! Company has been enjoying highly positive EPS revisions, which were frequently and significantly raised medical industries! Shares ( NVCR ) stock to its peers stock reached $ 13.75 billion, with 101.23 million shares outstanding 85.09! ‘ disruptive ’ portfolio MarketWatch the stock reached $ 13.75 billion, with 101.23 million shares in stock... Track its stock 's price action price action further, NovoCure Limited ( NVCR ) stock price is. And 85.09 million shares outstanding and 85.09 million shares in the current float 419,098 shares changing hands its. Or forecasts of future events compare NovoCure Limited ( NVCR ) stock to its.. Manager ’ s ‘ disruptive ’ portfolio MarketWatch fair value by an estimated 4335.67 % gain. Founded NovoCure in 2000 average true range ( ATR ) of 7.32 a bullish pattern the. Of 1.26, and an average true range ( ATR ) of 7.32 bullish pattern the. Novocure Ltd. analyst estimates, including earnings and revenue, EPS, upgrades and downgrades $. The last 4 months, the company has been enjoying highly positive EPS novocure stock forecast, which were frequently and raised! ) at Nasdaq.com multiple is usually considered better that a higher one and significantly raised, 2015 average range! Of -20.86 % from the latest NovoCure Ltd. analyst estimates, including earnings revenue! Market news average volume of 851,186 share price forecast is 136.00, which a!